Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
6,200
Employees6,200
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
6,200
Employees6,200

MEDP Key Statistics

Market cap
12.36B
Market cap12.36B
Price-Earnings ratio
27.23
Price-Earnings ratio27.23
Dividend yield
Dividend yield
Average volume
330.72K
Average volume330.72K
High today
$434.86
High today$434.86
Low today
$421.52
Low today$421.52
Open price
$431.71
Open price$431.71
Volume
233.23K
Volume233.23K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$287.17
52 Week low$287.17

Stock Snapshot

With a market cap of 12.36B, Medpace(MEDP) trades at $432.80. The stock has a price-to-earnings ratio of 27.23.

As of 2026-05-25, Medpace(MEDP) stock has fluctuated between $421.52 and $434.86. The current price stands at $432.80, placing the stock +2.7% above today's low and -0.5% off the high.

Medpace(MEDP) shares are trading with a volume of 233.23K, against a daily average of 330.72K.

In the last year, Medpace(MEDP) shares hit a 52-week high of $628.92 and a 52-week low of $287.17.

In the last year, Medpace(MEDP) shares hit a 52-week high of $628.92 and a 52-week low of $287.17.

MEDP News

Simply Wall St 1d
Assessing Medpace Holdings Valuation After Securities Class Actions And Fourth Quarter 2025 Fallout

Advertisement Why a wave of lawsuits has put Medpace Holdings (MEDP) in the spotlight Recent securities class actions against Medpace Holdings (MEDP) allege f...

Assessing Medpace Holdings Valuation After Securities Class Actions And Fourth Quarter 2025 Fallout
TipRanks 6d
Medpace shareholders approve governance changes enhancing voting rights

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

57%

of 14 ratings
Buy
35.7%
Hold
57.1%
Sell
7.1%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.